EMD at 30: where the evidence holds — and where it does not

Few regenerative materials have aged as well as enamel matrix derivative (EMD, Emdogain). Thirty years after its introduction, it remains a fixture of periodontal regeneration — and its indications keep expanding into endodontics, ridge preservation, implantology, and even dermatology and oncology-adjacent uses. This narrative review takes stock, synthesising English-language literature from 1996 to 2025 across PubMed, Scopus, and Cochrane Oral Health, prioritising clinical trials (preferentially RCTs) with at least six months of follow-up and folding in selective animal work to explain tissue-level mechanisms.

The evidence map is clear where EMD is strongest and honest where it is not. In mucogingival surgery, EMD raises the probability of complete root coverage and increases keratinised tissue width. In intrabony and certain furcation defects, EMD — alone or alongside bone grafts or membranes — improves clinical parameters and shows osteopromotive effects across preclinical and clinical models. Adjunctive use in peri-implantitis and implant-site regeneration shows promising effects on inflammatory and bone-regenerative endpoints. In vital pulp therapy, EMD supports tertiary dentinogenesis and dentine-bridge formation. Mechanistically, the common thread is biological: EMD enhances cell migration, proliferation, extracellular matrix deposition, and angiogenesis. The notable negative: EMD does little to preserve alveolar ridge dimensions after extraction — a useful boundary to know before reaching for it.

For the clinician, this is a consolidated, practical reference rather than a new finding. EMD is a validated adjunct in periodontal regeneration — especially recession coverage and intrabony defect management — with reparative properties that genuinely extend into endodontics and wound healing, while the cutaneous-ulcer data remain preliminary and sparse. The authors' agenda for the next decade is sensible: standardise dosing and regimens, explore controlled-release and combination formulations, and generate long-term effectiveness and cost-benefit data. A clear-eyed thirty-year audit of a material most periodontists already use, worth reading to calibrate where it earns its place and where it does not.